About Anaxomics
Anaxomics is a Healthcare company based in Barcelona (Spain) founded in 2005. It operates as a systems biology solutions are provided to industry and academia. Its focus areas include Biopharma Outsourcing, Consulting and Drug Discovery and Preclinical. Its competitors include Lupus Research, adMare BioInnovations, Glen Clova Scientific, Gradient and Bioassay and 3 more; 1 of its 8 listed competitors has raised funding.
Company details
Anaxomics is a biotechnology company that offers products and services to academia and the pharmaceutical industry centered around the principles of systems biology and their proprietary systems pharmacology framework called Therapeutic Performance Mapping System (TPMS). The TPMS framework is built around the integration of all available biological, pharmacological and medical knowledge into mathematical models that simulate in silico the behavior of human physiology. Anaxomics covers the entire drug discovery and development pipeline, from target discovery to pre-clinical development, proper design of clinical trials, product valuation and out-licensing, due diligence based on a combination of biological and pharmacological insight, and understanding of the market.
- Headquarters Barcelona, Spain
- SectorsHealthcare
- Email••••••••
- Website anaxomics.com
- Social LinkedIn
- Latest Funding Round$21.71K (USD), Grant
Dec 2022
- Investors
Funding Insights of Anaxomics
- Total Rounds 6
- Last Round Grant — $21,710
- Investors Count 1
All 6 funding rounds of Anaxomics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2022 | $21,710 | Grant | – | – | |
| Jan 2019 | $602,981 | Grant | – | – | |
| Jan 2018 | $297,715 | Grant | – | – | |
| Nov 2017 | $288,227 | Grant | – | – | |
| Jan 2017 | $235,649 | Grant | – | – | |
| Jan 2013 | – | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Anaxomics
Anaxomics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Anaxomics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Anaxomics
10 people are tracked at Anaxomics (6 in leadership, 4 in board & advisors).
| Name | Role | Group |
|---|---|---|
Laura Artigas | COO | Leadership |
Cristina Segu | Chief Compliance Officer | Leadership |
Peter M. Windisch | CEO | Leadership |
Jose Manuel Mas | Founder & CSO | Leadership |
Judith Farrés | Head, Collaborative Research | Leadership |
Mireia Coma | Medical Director | Leadership |
Xavier Daura | Advisor | Board & advisors |
Xavier Gomis | Advisor | Board & advisors |
Baldomero Oliva | Advisor | Board & advisors |
Joan Bigorra | Advisor | Board & advisors |
Complete people profiles for Anaxomics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Anaxomics
3 dated milestones of Anaxomics across 17 years, from founding to its latest funding, stage changes and deals.
- Founded Anaxomics is founded.
- Funding First funding round.
- Funding Latest funding round, Grant, of $22K.
Competitors of Anaxomics
Anaxomics has 8 listed competitors in our database, 1 of them funded. They include Lupus Research, adMare BioInnovations, Glen Clova Scientific, Gradient and Bioassay, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lupusresearch.org | 2016 | New York, United States | – | – | Offers consulting for drug discovery and preclinical development in healthcare. | |
| admarebio.com | 2019 | Vancouver, Canada | – | – | Biopharma consulting services are provided to clients by adMare BioInnovations. | |
| glenclovascientific.com | 2022 | Glasgow, United Kingdom | $4.96M | – | Developer of biologic drugs for chronic inflammatory conditions | |
| gradientcorp.com | 1985 | Concord, United States | – | 118 | Environmental and risk sciences consulting is offered to diverse industries. | |
| bioassay-online.de | 2002 | Heidelberg, Germany | – | 53 | Biological assays for pharmaceutical and chemical products are specialized in. | |
| advipro.be | 2003 | Antwerp, Belgium | – | 141 | Provides validation, engineering, and quality services in life sciences sectors. | |
| ccimia.com | 2006 | Bellevue, United States | – | – | Offers expert consulting services in pharmaceuticals, biotech, healthcare management, and medical devices worldwide. | |
| mediaiplus.com | 2018 | Incheon, South Korea | – | – | Clinical trial design services are provided in the healthcare sector. |
Detailed competitors of Anaxomics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
10 companies that operate in the same segment as Anaxomics (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Anaxomics
Anaxomics was founded in 2005 and raised its 1st funding round 8 years after it was founded.
Anaxomics is headquartered in Barcelona, Spain. It is registered at Barcelona, Catalonia, Spain.
Anaxomics is a biotechnology company that offers products and services to academia and the pharmaceutical industry centered around the principles of systems biology and their proprietary systems pharmacology framework called Therapeutic Performance Mapping System (TPMS). The TPMS framework is built around the integration of all available biological, pharmacological and medical knowledge into mathematical models that simulate in silico the behavior of human physiology. Anaxomics covers the entire drug discovery and development pipeline, from target discovery to pre-clinical development, proper design of clinical trials, product valuation and out-licensing, due diligence based on a combination of biological and pharmacological insight, and understanding of the market.
Anaxomics's top competitors include adMare BioInnovations, Bioassay and Gradient.
Anaxomics has 1 investor. Key investors include European Union.